Quantum Biopharma Ltd.
QNTM · XNASCIK 1771885fmd_0VHC93404JC10M6V86CZQC7T2NManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2018 to Dec 31, 2025, 16 periods
| Line item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Research and development | 0 | 8 | 6 | 7 | 4 | 6 | 3 |
| Selling, general and administrative | – | – | – | 15 | 9 | 9 | 9 |
| Operating income | (22) | (31) | (34) | (27) | (24) | (16) | (15) |
| Interest expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | (34) | (28) | (34) | (27) | (18) | (15) | (27) |
| Net income | (39) | (32) | (35) | (24) | – | – | – |